Infertility, Female
Conditions
Keywords
In Vitro Oocyte Maturation Techniques
Brief summary
In vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lower health risk profile of IVM compared to controlled ovarian stimulation (COS) in polycystic ovary syndrome (PCOS) patients, the use of IVM in selected patients may gain increasing interest. Besides its application in patients with polycystic ovaries, IVM technology may have a role in fertility preservation, where young girls and adult women are facing infertility due to gonadotoxic chemotherapeutic treatment.
Interventions
PROCEDURECAPA IVM
In CAPA-IVM, the oocyte is treated and matured outside the woman's body, while in classical IVF, the patient is treated. As a consequence, patients undergoing CAPA-IVM are not confronted with the typical risks and burden of systemic ovarian stimulation.
Sponsors
Chinese University of Hong Kong
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
0 Months to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients aged from 0-50 years old * Patients seek fertility preservation services * Patients seek oocyte retrieval services
Exclusion criteria
-Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| No. of mature oocytes | 1 week | Number of mature oocytes after IVM |
Countries
Hong Kong
Contacts
Primary ContactPui Wah Jacqueline Chung
Outcome results
None listed